| DT |
2026-09-03 16:40 |
2026-07-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$33.50 |
+279 |
27.7K |
+1% |
+$9,346 |
| DMT |
2026-09-03 16:40 |
2026-09-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+11.5K |
39.2K |
+42% |
— |
| DT |
2026-09-03 16:40 |
2026-09-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$79.28 |
-5,531 |
33.7K |
-14% |
-$438.5K |
| DT |
2026-09-03 16:40 |
2026-09-03 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$80.30 |
-4,600 |
29.1K |
-14% |
-$369.4K |
| T |
2026-04-13 16:35 |
2026-04-09 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale |
$46.69 |
-6,625 |
27.4K |
-19% |
-$309.3K |
| D |
2026-04-08 16:38 |
2026-04-07 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$1.00 |
+3,932 |
35.7K |
+12% |
+$3,932 |
| D |
2026-04-08 16:38 |
2026-04-07 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$48.94 |
-1,666 |
34.0K |
-5% |
-$81.5K |
| D |
2026-04-03 16:34 |
2026-01-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$24.16 |
+372 |
27.4K |
+1% |
+$8,988 |
| D |
2026-04-03 16:34 |
2026-04-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+7,564 |
35.0K |
+28% |
— |
| D |
2026-04-03 16:34 |
2026-04-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$48.13 |
-3,205 |
31.8K |
-9% |
-$154.3K |
| DM |
2025-10-22 |
2025-10-20 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$11.59 |
+39.4K |
77.5K |
+104% |
+$457.0K |
| DM |
2025-10-22 |
2025-10-20 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$38.87 |
-50.5K |
27.0K |
-65% |
-$1.96M |
| D |
2025-10-08 |
2025-10-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$38.49 |
-85 |
38.1K |
-0.2% |
-$3,272 |
| D |
2025-10-08 |
2025-10-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+175 |
38.2K |
+0.5% |
— |
| DM |
2025-09-03 |
2025-09-01+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$17.92 |
+20.6K |
35.4K |
+140% |
+$369.6K |
| DM |
2025-09-03 |
2025-09-01+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$33.55 |
-4,657 |
37.6K |
-11% |
-$156.3K |
| D |
2025-09-03 |
2025-09-03 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$34.84 |
-11.0K |
38.0K |
-22% |
-$383.2K |
| D |
2025-08-06 |
2025-07-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$15.63 |
+495 |
33.0K |
+2% |
+$7,737 |
| D |
2025-08-06 |
2025-08-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$15.52 |
+17.0K |
50.0K |
+51% |
+$263.8K |
| D |
2025-08-06 |
2025-08-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$32.35 |
-17.0K |
33.0K |
-34% |
-$550.0K |
| D |
2025-06-05 |
2025-06-03 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$15.50 |
+15.2K |
47.8K |
+47% |
+$235.8K |
| D |
2025-06-05 |
2025-06-03 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$28.75 |
-15.2K |
32.5K |
-32% |
-$437.3K |
| DM |
2025-05-09 |
2025-05-07 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$12.53 |
+17.6K |
50.2K |
+54% |
+$221.1K |
| D |
2025-05-09 |
2025-05-07 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$26.69 |
-17.6K |
32.5K |
-35% |
-$471.0K |
| D |
2025-04-09 |
2025-04-07 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$20.28 |
-1,666 |
32.5K |
-5% |
-$33.8K |
| D |
2025-04-09 |
2025-04-07 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+3,933 |
34.2K |
+13% |
— |
| DM |
2025-04-03 |
2025-04-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$21.77 |
-2,084 |
31.3K |
-6% |
-$45.4K |
| DM |
2025-04-03 |
2025-04-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+4,920 |
32.4K |
+18% |
— |
| D |
2025-03-19 |
2025-01-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$16.00 |
+469 |
27.0K |
+2% |
+$7,504 |
| D |
2025-03-19 |
2025-03-16 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+774 |
27.8K |
+3% |
— |
| D |
2025-03-19 |
2025-03-16 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$22.61 |
-328 |
27.4K |
-1% |
-$7,416 |
| D |
2025-03-14 |
2025-03-12 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$11.10 |
+9,051 |
35.6K |
+34% |
+$100.5K |
| D |
2025-03-14 |
2025-03-12 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$22.45 |
-9,051 |
26.5K |
-25% |
-$203.2K |
| DM |
2024-12-02 |
2024-11-27+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$22.45 |
-8,646 |
26.5K |
-25% |
-$194.1K |
| DM |
2024-12-02 |
2024-11-27+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$11.10 |
+8,646 |
35.2K |
+33% |
+$96.0K |
| D |
2024-10-08 |
2024-10-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+175 |
26.6K |
+0.7% |
— |
| D |
2024-10-08 |
2024-10-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$24.48 |
-82 |
26.5K |
-0.3% |
-$2,007 |
| DM |
2024-09-04 |
2024-09-01+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+7,265 |
26.8K |
+37% |
— |
| D |
2024-09-04 |
2024-07-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$15.65 |
+480 |
22.3K |
+2% |
+$7,512 |
| DM |
2024-09-04 |
2024-09-01+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$26.74 |
-3,084 |
26.0K |
-11% |
-$82.5K |
| D |
2024-04-08 |
2024-04-08 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+3,932 |
23.0K |
+21% |
— |
| D |
2024-04-08 |
2024-04-08 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$17.90 |
-1,666 |
21.3K |
-7% |
-$29.8K |
| D |
2024-04-03 |
2024-04-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+2,558 |
20.1K |
+15% |
— |
| D |
2024-04-03 |
2024-04-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$19.70 |
-1,084 |
19.1K |
-5% |
-$21.4K |
| D |
2024-03-01 |
2024-01-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$12.35 |
+583 |
17.6K |
+3% |
+$7,200 |
| DM |
2024-03-01 |
2024-02-28+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$10.20 |
+14.8K |
27.2K |
+119% |
+$150.8K |
| DM |
2024-03-01 |
2024-02-28+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$21.57 |
-14.8K |
17.6K |
-46% |
-$318.9K |
| D |
2024-01-04 |
2024-01-02 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$13.88 |
+16.7K |
33.7K |
+98% |
+$231.4K |
| D |
2024-01-04 |
2024-01-02 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$19.17 |
-16.7K |
17.0K |
-50% |
-$319.6K |
| D |
2023-12-21 |
2023-12-19 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
S - Sale+OE |
$19.13 |
-9,316 |
17.0K |
-35% |
-$178.2K |
| D |
2023-12-21 |
2023-12-19 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
$13.88 |
+9,316 |
26.3K |
+55% |
+$129.3K |
| D |
2023-10-06 |
2023-10-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+175 |
17.1K |
+1% |
— |
| D |
2023-10-06 |
2023-10-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$16.01 |
-52 |
17.0K |
-0.3% |
-$832.52 |
| D |
2023-09-06 |
2023-07-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$12.35 |
+581 |
13.6K |
+4% |
+$7,175 |
| DM |
2023-09-06 |
2023-09-01+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+4,707 |
17.1K |
+38% |
— |
| DM |
2023-09-06 |
2023-09-01+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$17.76 |
-1,383 |
16.3K |
-8% |
-$24.6K |
| D |
2023-04-11 |
2023-04-10 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$10.71 |
-1,155 |
13.0K |
-8% |
-$12.4K |
| D |
2023-04-11 |
2023-04-10 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+3,933 |
14.1K |
+39% |
— |
| D |
2023-03-20 |
2023-01-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$9.56 |
+704 |
8,118 |
+9% |
+$6,730 |
| DM |
2023-03-20 |
2023-03-16+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+2,937 |
10.8K |
+37% |
— |
| DM |
2023-03-20 |
2023-03-16+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$11.21 |
-856 |
10.2K |
-8% |
-$9,594 |
| D |
2022-10-06 |
2022-10-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+175 |
7,466 |
+2% |
— |
| D |
2022-10-06 |
2022-10-04 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$14.23 |
-52 |
7,414 |
-0.7% |
-$739.96 |
| D |
2022-09-06 |
2022-09-02 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+775 |
7,519 |
+11% |
— |
| D |
2022-09-06 |
2022-07-15 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$9.56 |
+703 |
6,744 |
+12% |
+$6,721 |
| D |
2022-09-06 |
2022-09-02 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$11.44 |
-228 |
7,291 |
-3% |
-$2,608 |
| D |
2022-03-23 |
2022-03-21 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$10.98 |
-1,120 |
6,041 |
-16% |
-$12.3K |
| D |
2022-03-23 |
2022-03-21 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+3,231 |
7,161 |
+82% |
— |
| DM |
2022-03-18 |
2020-06-30+ |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
A - Grant |
$11.03 |
+2,287 |
2,771 |
+473% |
+$25.2K |
| D |
2022-03-18 |
2022-03-16 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
M - OptEx |
— |
+775 |
4,199 |
+23% |
— |
| D |
2022-03-18 |
2022-03-16 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Megna Michael R |
CAO |
F - Tax |
$10.13 |
-269 |
3,930 |
-6% |
-$2,725 |